Cancer Research UK – Radiation Research Conference 2027
Cancer Research UK – Radiation Research Conference 2027 Oncodaily
Cancer Research UK – Radiation Research Conference 2027 Oncodaily
The FDA has expanded its approval of talazoparib in combination with enzalutamide to include men with metastatic androgen pathway modulation-naive or -sensitive prostate cancer with homologous recombination repair gene mutations. “This approval represents a critical advancement for patients with newly diagnosed…
Bringing AI to the data: the future of privacy-compliant cancer research European Society For Medical Oncology | ESMO
A more effective and better-tolerated treatment for chronic myeloid leukemia (CML) could improve quality of life for people living with the disease. A new study led by Adelaide University and the South Australian Health and Medical Research Institute (SAHMRI) has provided the first direct evidence that a targeted…
GSK’s Positive Cancer Trial Results Reveal Oncology Momentum Healthcare Digital
GSK to nearly double cancer medicines in clinical trials next year Reuters
Experimental T-cell therapy shows promise against treatment-resistant cancers Open Access Government
Скрининги по ОМС в Подмосковье: что и когда нужно пройти каждому для защиты от рака REGIONS.ru
Монголия и канада будут сотрудничать в области раннего выявления рака легких AsiaRussia
В США научили ИИ находить скрытые признаки рака поджелудочной железы ФармМедПром
Mexico authorizes its first domestic CAR-T trial for leukemia patients who have exhausted other treatments Latin Times
BYU preclinical research shows macrophages can be programmed to fight solid cancer tumors BYU News
ESMO26: Breast cancer treatment landscape continues to be redefined Clinical Trials Arena